{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
DaVita, Inc.
DaVita, Inc. Hits 52-Week Low at USD 122.92 Amid Financial Struggles
DaVita, Inc. has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio, despite a modest growth rate in operating profit over the last five years.
DaVita, Inc. Stock Plummets to New 52-Week Low of $123.15
DaVita, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio. Its performance has lagged behind broader market trends, indicating ongoing difficulties.
Is DaVita, Inc. technically bullish or bearish?
As of September 10, 2025, DaVita, Inc. exhibits a bearish technical trend, with negative performance indicators and year-to-date returns of -12.92%, significantly underperforming the S&P 500.
Is DaVita, Inc. overvalued or undervalued?
As of May 12, 2025, DaVita, Inc. is considered risky and overvalued with a P/E ratio of 10, an EV to EBITDA ratio of 7.83, and poor performance compared to peers and the S&P 500, indicating a negative investment outlook.
Is DaVita, Inc. overvalued or undervalued?
As of May 12, 2025, DaVita, Inc. is considered undervalued with a P/E ratio of 10 and an EV to EBITDA of 7.83, indicating potential for recovery despite recent underperformance compared to the S&P 500.
Is DaVita, Inc. technically bullish or bearish?
As of May 28, 2025, DaVita, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD, moving averages, and Bollinger Bands, alongside a mildly bearish monthly outlook.
Who are in the management team of DaVita, Inc.?
As of March 2022, DaVita, Inc.'s management team includes CEO Javier Rodriguez and several independent directors, including Pamela Arway (Chair), Charles Berg, Shawn Guertin, Barbara Desoer, Paul Diaz, and John Nehra.
What does DaVita, Inc. do?
DaVita, Inc. provides kidney dialysis services for chronic kidney failure patients and has a market capitalization of approximately $11.36 billion. As of March 2025, it reported net sales of $3.22 billion and a net profit of $232 million.
How big is DaVita, Inc.?
As of Jun 18, DaVita, Inc. has a market capitalization of $11.36 billion, with net sales of $12.97 billion and a net profit of $1.18 billion for the latest four quarters. The balance sheet shows shareholder's funds of $121.12 million and total assets of $17.97 billion.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
